Načítá se...
Nonparametric Benefit–Risk Assessment Using Marker Process in the Presence of a Terminal Event
Benefit–risk assessment is a crucial step in medical decision process. In many biomedical studies, both longitudinal marker measurements and time to a terminal event serve as important endpoints for benefit–risk assessment. The effect of an intervention or a treatment on the longitudinal marker proc...
Uloženo v:
| Vydáno v: | J Am Stat Assoc |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5935274/ https://ncbi.nlm.nih.gov/pubmed/29731529 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/01621459.2016.1180988 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|